ESR1 and breast cancer: Similarly, MCF7 cells are commonly used for BC, characterized by estrogen receptor positivity and moderate sensitivity to chemotherapeutics like paclitaxel (PTX), making them a standard model for studying HR+ BC and mechanisms of taxane resistance (Neve et al., 2006).